Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (61-70 of 1,023) with videos related to

Pageof 103
Sort By:
Circulation. Genomic and Precision Medicine|October 26, 2018
SLCO1B1 and Statin TherapySony Tuteja, Daniel J Rader
Clinical Chemistry|April 1, 2008
Laboratory assessment of HDL heterogeneity and functionRajesh Movva, Daniel J Rader
Nature Reviews. Endocrinology|September 3, 2014
Dyslipidaemia: cardiovascular prevention--end of the road for niacin?Sony Tuteja, Daniel J Rader
The Lancet. Diabetes & Endocrinology|March 26, 2016
Recent advances in the pharmacological management of hypercholesterolaemiaEzim Ajufo, Daniel J Rader
The American Journal of Clinical Nutrition|September 15, 2017
Can changes in the plasma lipidome help explain the cardiovascular benefits of the Mediterranean diet?Archna Bajaj, Daniel J Rader
Current Opinion in Lipidology|April 19, 2013
Microsomal transfer protein inhibition in humansMarina Cuchel, Daniel J Rader
Molecular Medicine Today|March 31, 2000
Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis preventionD J Rader, C Maugeais
Thescientificworldjournal|June 14, 2003
The role of high density lipoproteins in thrombosisMarina Cuchel, Daniel J Rader
Current Atherosclerosis Reports|June 14, 2006
Human genetics of variation in high-density lipoprotein cholesterolAtif Qasim, Daniel J Rader
Personalized Medicine|May 20, 2018
Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular diseaseSony Tuteja, Daniel J Rader
Pageof 103

Showing results (61-70 of 1,023) with videos related to

Sort By:
Pageof 103
Circulation. Genomic and Precision Medicine|October 26, 2018
SLCO1B1 and Statin TherapySony Tuteja, Daniel J Rader
Clinical Chemistry|April 1, 2008
Laboratory assessment of HDL heterogeneity and functionRajesh Movva, Daniel J Rader
Nature Reviews. Endocrinology|September 3, 2014
Dyslipidaemia: cardiovascular prevention--end of the road for niacin?Sony Tuteja, Daniel J Rader
The Lancet. Diabetes & Endocrinology|March 26, 2016
Recent advances in the pharmacological management of hypercholesterolaemiaEzim Ajufo, Daniel J Rader
The American Journal of Clinical Nutrition|September 15, 2017
Can changes in the plasma lipidome help explain the cardiovascular benefits of the Mediterranean diet?Archna Bajaj, Daniel J Rader
Current Opinion in Lipidology|April 19, 2013
Microsomal transfer protein inhibition in humansMarina Cuchel, Daniel J Rader
Molecular Medicine Today|March 31, 2000
Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis preventionD J Rader, C Maugeais
Thescientificworldjournal|June 14, 2003
The role of high density lipoproteins in thrombosisMarina Cuchel, Daniel J Rader
Current Atherosclerosis Reports|June 14, 2006
Human genetics of variation in high-density lipoprotein cholesterolAtif Qasim, Daniel J Rader
Personalized Medicine|May 20, 2018
Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular diseaseSony Tuteja, Daniel J Rader
Pageof 103